Protalix BioTherapeutics Inc (PLX)
1.69
+0.03
(+1.81%)
USD |
NYAM |
Nov 22, 16:00
1.70
+0.01
(+0.59%)
After-Hours: 20:00
Protalix BioTherapeutics Stock Buybacks (Quarterly): 0.00 for Sept. 30, 2024
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 0.00 |
June 30, 2024 | 0.00 |
March 31, 2024 | 0.00 |
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | -9.721M |
March 31, 2023 | -14.23M |
December 31, 2022 | -4.075M |
September 30, 2022 | -1.52M |
June 30, 2022 | -2.641M |
March 31, 2022 | |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | -46.20M |
December 31, 2020 | -4.867M |
September 30, 2020 | -4.00M |
June 30, 2020 | 1.264M |
March 31, 2020 | -38.61M |
December 31, 2019 | |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 |
Date | Value |
---|---|
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | |
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | 0.00 |
September 30, 2012 | 0.15M |
June 30, 2012 | 0.06M |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-46.20M
Minimum
Mar 2021
1.264M
Maximum
Jun 2020
-6.922M
Average
-0.76M
Median
Stock Buybacks (Quarterly) Benchmarks
Accuray Inc | -- |
Aethlon Medical Inc | 0.00 |
AIM ImmunoTech Inc | -0.004M |
Perspective Therapeutics Inc | 0.123M |
Armata Pharmaceuticals Inc | -- |